Integra Lifesciences Holdings (IART) Other Non Operating Income (2009 - 2026)

Integra Lifesciences Holdings has reported Other Non Operating Income for 18 years, with the latest figure at $4.2 million in Q2 2026.

• Quarterly Other Non Operating Income rose 315.11% year-over-year to $4.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.4 million (up 718.4% YoY) and the FY2025 annual result came in at -$2.4 million, down 159.61% from the prior year.
• Other Non Operating Income retreated to $4.2 million in Q2 2026 per IART's latest filing, from $4.5 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $4.5 million in Q1 2026 and troughed at -$1.9 million in Q2 2025.
• A 5-year average of $1.4 million and a median of $1.4 million in 2023 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2025 and 2026: Other Non Operating Income tumbled 235.42% in 2025, then surged 3211.11% in 2026.
• Over 5 years, Other Non Operating Income stood at $4.0 million in 2022, then sank by 49.05% to $2.0 million in 2023, then plunged by 50.07% to $1.0 million in 2024, then slumped by 42.19% to $581000.0 in 2025, then surged by 620.48% to $4.2 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $4.2 million, $4.5 million, and $581000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.